IGC Stock Analysis: Buy, Sell, or Hold?
IGC - IGC Pharma, Inc.
$0.30
0.00 (-0.27%)
âŧ
5d:
-3.83%
30d:
+19.31%
90d:
-1.37%
WAIT
LOW Confidence
Analysis Updated: Sep 2, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When IGC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: IGC is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: IGC is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: IGC is currently trading at $0.30, which is considered slightly high relative to its 30-day fair value range of $0.25 to $0.30.
Technical Outlook: Technically, IGC is in a uptrend. Immediate support is located at $0.27, while resistance sits at $0.34.
Market Sentiment: IGC scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $4.50 (+1420.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, IGC is in a uptrend. Immediate support is located at $0.27, while resistance sits at $0.34.
Market Sentiment: IGC scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $4.50 (+1420.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$0.25 -
$0.30
Company Quality Score
42/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
42.1%
All Signals
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1420.8% below Wall St target ($4.50)
- WARNING: Composite score 42/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.25 -
$0.30
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$0.27
Resistance Level
$0.34
Current Trend
Uptrend
Technical data as of
Sep 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.29
Wall Street Target
$4.50
(+1420.8%)
Revenue Growth (YoY)
-19.2%
Share & Embed Analysis
Last updated: September 02, 2026 7:45 PM ET
Data refreshes hourly during market hours. Next update: 8:45 PM
Data refreshes hourly during market hours. Next update: 8:45 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IGC showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$55 | 59 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 58 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 42 HOLD |
|
GPCR
Structure Therapeutics IâĻ |
STRONG BUY
14 analysts |
$105 | 56 HOLD |
|
RCKT
Rocket Pharmaceuticals IâĻ |
STRONG BUY
18 analysts |
$9 | 40 HOLD |
